On Tuesday, Biolife Solutions Inc (NASDAQ: BLFS) opened higher 9.62% from the last session, before settling in for the closing price of $20.47. Price fluctuations for BLFS have ranged from $11.91 to $28.88 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 57.29% over the last five years. Company’s average yearly earnings per share was noted 67.76% at the time writing. With a float of $45.18 million, this company’s outstanding shares have now reached $46.39 million.
The firm has a total of 414 workers. Let’s measure their productivity. In terms of profitability, gross margin is 45.95%, operating margin of -22.55%, and the pretax margin is -26.26%.
Biolife Solutions Inc (BLFS) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Medical Instruments & Supplies industry is another important factor to consider. The insider ownership of Biolife Solutions Inc is 2.61%, while institutional ownership is 99.03%. The most recent insider transaction that took place on Nov 15 ’24, was worth 529,150. In this transaction EVP & Chief Scientific Officer of this company sold 25,000 shares at a rate of $21.17, taking the stock ownership to the 302,046 shares. Before that another transaction happened on Nov 18 ’24, when Company’s EVP & Chief Scientific Officer sold 17,604 for $20.05, making the entire transaction worth $352,960. This insider now owns 284,442 shares in total.
Biolife Solutions Inc (BLFS) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.21 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.27) by 0.06. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.04 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 67.76% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 10.00% during the next five years compared to 0.51% growth over the previous five years of trading.
Biolife Solutions Inc (NASDAQ: BLFS) Trading Performance Indicators
Check out the current performance indicators for Biolife Solutions Inc (BLFS). In the past quarter, the stock posted a quick ratio of 1.78. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.44. Likewise, its price to free cash flow for the trailing twelve months is 184.24.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.82, a number that is poised to hit -0.09 in the next quarter and is forecasted to reach -0.24 in one year’s time.
Technical Analysis of Biolife Solutions Inc (BLFS)
Analysing the last 5-days average volume posted by the [Biolife Solutions Inc, BLFS], we can find that recorded value of 0.82 million was better than the volume posted last year of 0.38 million. As of the previous 9 days, the stock’s Stochastic %D was 15.13%. Additionally, its Average True Range was 1.56.
During the past 100 days, Biolife Solutions Inc’s (BLFS) raw stochastic average was set at 36.74%, which indicates a significant increase from 31.56% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 81.40% in the past 14 days, which was higher than the 58.11% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $23.92, while its 200-day Moving Average is $21.22. Now, the first resistance to watch is $23.31. This is followed by the second major resistance level at $24.18. The third major resistance level sits at $25.85. If the price goes on to break the first support level at $20.77, it is likely to go to the next support level at $19.10. Now, if the price goes above the second support level, the third support stands at $18.23.
Biolife Solutions Inc (NASDAQ: BLFS) Key Stats
There are currently 46,387K shares outstanding in the company with a market cap of 1.04 billion. Presently, the company’s annual sales total 143,270 K according to its annual income of -66,430 K. Last quarter, the company’s sales amounted to 30,570 K and its income totaled -1,700 K.
